CELLCENTRIC LIMITED

Active Cambridge

Research and experimental development on biotechnology

19 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
C

CELLCENTRIC LIMITED

Research and experimental development on biotechnology

Founded 30 Oct 2003 Active Cambridge, United Kingdom 19 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 2 Oct 2025 Next due 30 Sept 2026 5 months remaining
Confirmation Submitted 10 Jun 2025 Next due 27 May 2026 28 days remaining
Net assets £38M £37M 2024 year on year
Total assets £41M £16M 2024 year on year
Total Liabilities £3M £21M 2024 year on year
Charges 6
6 satisfied

Contact & Details

Contact

Registered Address

Chesterford Research Park Little Chesterford Cambridge CB10 1XL

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for CELLCENTRIC LIMITED (04948632), an active life sciences and medical technology company based in Cambridge, United Kingdom. Incorporated 30 Oct 2003. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2015–2024)

Cash in Bank

£38.42M

Increased by £14.49M (+61%)

Net Assets

£37.72M

Increased by £36.94M (+4784%)

Total Liabilities

£3.33M

Decreased by £21.33M (-86%)

Turnover

N/A

Employees

19

Decreased by 1 (-5%)

Debt Ratio

8%

Decreased by 89 (-92%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 8

Investors (5)

Investor NameInvestor SinceParticipating Rounds
Investor 4Jan 2022Series C, Strategic Investment
Investor 1Jul 2024Series C, Strategic Investment
Investor 5Jul 2024Strategic Investment

Share Capital

Share Capital

Share allotments and capital structure

38 Allotments 80,965,843 Shares £171.83m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
1 Dec 202550,000£50£0.001
3 Oct 20252,772,000£3k£0.001
3 Oct 20252,772,000£3k£0.001
22 Apr 202513,389,225£47.04m£3.513
23 Oct 20241,680,000£2k£0.001

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (54)

Morningside Venture Investments Ltd
76.5%
39,761,177
Providence Investment Company Limited
6.9%
3,595,806

Persons with Significant Control

Persons with Significant Control (2)

2 Active 2 Ceased

Yuk Lan Wong

Hong Konger

Active
Notified 15 Jan 2020
Residence Hong Kong
DOB March 1967
Nature of Control
  • Significant Influence Or Control As Trust

Adriel Wenbwo Chan

Hong Konger

Active
Notified 15 Jan 2020
Residence Hong Kong
DOB July 1982
Nature of Control
  • Significant Influence Or Control As Trust

Morningside Venture Investments Ltd

Ceased 6 Apr 2016

Ceased

Madam Chan Tan Ching Fen

Ceased 15 Jan 2020

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

6 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
21 Apr 2026CapitalAllotment of shares (GBP 100,074.153) on 29 Jan 2026
16 Dec 2025CapitalAllotment of shares (GBP 86,684.928) on 1 Dec 2025
14 Oct 2025CapitalAllotment of shares (GBP 86,634.928) on 3 Oct 2025
6 Oct 2025IncorporationMemorandum Articles
2 Oct 2025AccountsAnnual accounts made up to 31 Dec 2024
21 Apr 2026 Capital

Allotment of shares (GBP 100,074.153) on 29 Jan 2026

16 Dec 2025 Capital

Allotment of shares (GBP 86,684.928) on 1 Dec 2025

14 Oct 2025 Capital

Allotment of shares (GBP 86,634.928) on 3 Oct 2025

6 Oct 2025 Incorporation

Memorandum Articles

2 Oct 2025 Accounts

Annual accounts made up to 31 Dec 2024

Recent Activity

Latest Activity

Allotment of shares (GBP 100,074.153) on 29 Jan 2026

1 weeks ago on 21 Apr 2026

Allotment of shares (GBP 86,684.928) on 1 Dec 2025

4 months ago on 16 Dec 2025

Allotment of shares (GBP 86,634.928) on 3 Oct 2025

6 months ago on 14 Oct 2025

Memorandum Articles

6 months ago on 6 Oct 2025

Annual accounts made up to 31 Dec 2024

6 months ago on 2 Oct 2025